Nonpenetrating brachytherapy device shows positive early safety, efficacy results

SEATTLE — A new brachytherapy approach has been shown to increase best corrected visual acuity and was well-tolerated in a small group of patients with age-related macular degeneration, according to a poster presentation here. Kamaljit S. Balaggan, MBBS, and colleagues presented a poster at the Association for Research in Vision and Ophthalmology meeting on the early results with the SMD-1 novel episcleral brachytherapy device developed by SalutarisMD. The class 1 medical device delivers 24 Gy of radiation for 5.5 minutes to the macula through a probe placed adjacent to the (Read more...)

Full Story →